ABSTRACT
A study is presented of the lipid and mineral metabolism composition in 60 patients with diseases of the biliary tract (dyskinesias, chronic noncalculous cholecystitis, cholelithiasis) before and after treatment with a hepatoprotective agent silibor, with a dry protein mixture containing amino acids and minerals and a vitamin-mineral agent quadevit. It was established that the patients showed disorders of the mineral and lipid composition of monotypical character but of different degrees of severity in those suffering of dyskinesias, cholecystitis and cholelithiasis. Silibor treatment furthered normalization of the lipid composition of bile, while treatment with dry protein mixture--of the mineral, with quadevit--of the lipid and mineral.
Subject(s)
Bile/drug effects , Cholelithiasis/prevention & control , Lipid Metabolism , Trace Elements/metabolism , Amino Acids/therapeutic use , Bile/analysis , Bile/metabolism , Biliary Dyskinesia/complications , Biliary Dyskinesia/drug therapy , Biliary Dyskinesia/metabolism , Blood Proteins/therapeutic use , Cholecystitis/complications , Cholecystitis/drug therapy , Cholecystitis/metabolism , Cholelithiasis/etiology , Cholelithiasis/metabolism , Copper/therapeutic use , Drug Combinations/therapeutic use , Flavonoids/therapeutic use , Humans , Lipids/analysis , Milk Proteins/therapeutic use , Potassium/therapeutic use , Trace Elements/analysis , Vitamins/therapeutic useABSTRACT
A study of 60 patients with biliary tract diseases revealed different disorders of the lipid and mineral composition of bile of monotypical character but different by severity in patients with dyskinesias, cholecystitis and cholelithiasis. Silibor favours normalization of the lipid composition of bile, a dry protein mixture--the mineral composition quadevit--the mineral and lipid composition of bile.
